Image1 (Prochlorperazine 1)
Prochlorperazine Edisylate Injection
Product Images NDC 65145-119
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Prochlorperazine Edisylate (NDC 65145-119). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Caplin Steriles Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image-2 (Prochlorperazine 2)
This is a description for Prochlorperazine Edisylate Injection, USP. The medication is used for deep intramuscular or intravenous use only and should not be used subcutaneously. The injection contains 10 mg/2mL (5 mg/r) of prochlorperazine edisylate and comes in 2 mL multiple-dose vial. It is important to protect the medication from light. The text also includes a code for the medication and a lot number, but the expiration date is not readable.*
Image-3-2 (Prochlorperazine 3 1)
This is a description of a medication vial containing Prochlorperazine Edisylate Injection, USP. The vial has a volume of 2 mL and contains 10 mg of the drug per 2 mL (5mg/mL). It is intended for deep intramuscular or intravenous use only and must be protected from light. The package contains 25 vials, each with a capacity of 2 mL. The vials were manufactured by Gaplin Steriles Limited in India and are for RX use only. The NDC number is 65145-119-25.*
Image-3-1 (Prochlorperazine 3 2)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
